why choose us

Clinical Trials Search

Showing 18,770 of 132,963 result(s)
Pilot of Osanetant to Reduce Testosterone in Men With Adenocarcinoma of the Prostate

Status: Completed

Condition: Prostate Adenocarcinoma

Interventions: To evaluate the effect of Osanetant on the testosterone levels.

Date: 2022-10-31

Inhaled Nitric Oxide for Microvascular Dysfunction in Traumatic Brain Injury

Status: NOT_YET_RECRUITING

Condition: Traumatic Brain Injury

Interventions: iNO will be provided by ventilator or nasal cannula for 4 hours each day.

Date: 2022-10-31

Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa

Status: Completed

Condition: Depression

Interventions: Aims 1 (n=30) and 2 (n=18) will inform the Aim 3 intervention.
We anticipate that the intervention will be comprised of four treatment sessions.<

Date: 2022-10-31

Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients

Status: Completed

Condition: Brain Tumor

Interventions: Radiation Therapy with substructure informed planning determined by the PI.

Date: 2022-10-31

Validation of a Low-cost Platelet-Rich Plasma (PRP)

Status: ACTIVE_NOT_RECRUITING

Condition: Platelet-Rich Plasma (PRP)

Interventions: Blood Collection 45mL, Processed Neutrophil-Poor PRP, 2 Injections at day 0 and 3 weeks.

Date: 2022-10-31

1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV

Status: Completed

Condition: Violence, Domestic

Interventions: Cognitive behavioral intervention to reduce HIV and IPV stigma.

Date: 2022-10-31

A Second Trial of the Abbreviated Protocol Two-Stage Exchange

Status: Completed

Condition: Prosthetic-joint Infection

Interventions: Seven-day local antibiotic irrigation (alternating vancomycin hydrochloride and tobramycin sulfate) via the temporary VT-X7 Knee or Hip Spacer.

Date: 2022-10-31

Evaluating the Efficacy and Safety of Metformin in Vitiligo

Status: Completed

Condition: Vitiligo

Interventions:

Consistent with previous studies and clinical recommendations, subjects will initiate treatment at metformin 500 mg twice daily and increase to 100

Date: 2022-10-31

A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours

Status: Completed

Condition: Pancreatic Ductal Adenocarcinoma (PDAC)

Interventions:

[225Ac]-FPI-2059 is a targeted alpha therapeutic that consists of an NTSR1-targeting small molecule that is linked to Ac-225, an alpha particle emi

Date: 2022-10-31

Preventing Distracted Driving Phase II

Status: Completed

Condition: Distracted Driving

Interventions: Participants will receive a Bluetooth device to use for the duration of the study, and will use the app with all features turned on.

Date: 2022-10-31